61 completed, 22 unknown, 21 terminated, 11 recruiting. 131 Phase 2, 15 Phase 3, 8 Phase 1.
Follow Spondylarthropathies: new trials by email Literature Review of Spondylarthropathies trials Research Report on Spondylarthropathies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Extension Study of Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis (CDDY391A12201-extension) DDY391 - Moderate to Severe Psoriatic Arthritis | Phase 2 | Not yet recruiting | Novartis Pharmaceuticals | 88 | 2027-02-10 | 2026-11-06 |
| Phase 2 Trial of FT2109 for the Treatment of Psoriatic Arthritis FT2109 Dosing Regimen 1, FT2109 Dosing Regimen 2, Matching Placebo - Psoriatic Arthritis (PsA) | Phase 2 | Not yet recruiting | Forward Therapeutics | 210 | 2026-12-01 | 2026-10-09 |
| A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis DDY391, Placebo - Moderate to Severe Psoriatic Arthritis | Phase 2 | Recruiting | Novartis Pharmaceuticals | 220 | 2026-10-19 | 2026-11-09 |
| Vilamakitug in Spondyloarthritis Placebo-controlled Investigation for Efficacy vilamakitug, placebo - Axial Spondyloarthritis, Ankylosing Spondylitis | Phase 2 | Not yet recruiting | XBiotech, Inc. | 150 | 2026-09-01 | 2026-05-14 |
| A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis TQH3906 Capsule, TQH3906 Placebo Capsule, Tofacitinib Citrate Tablet 5 mg - Psoriatic Arthritis | Phase 2 | Recruiting | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 156 | 2026-07-16 | 2026-09-02 |
| Oral CBP-0276 or Placebo in Adults With Active Psoriatic Arthritis (PsA) CBP-0276 capsules 100mg, Placebo - Arthritic Psoriasis | Phase 2 | Not yet recruiting | Clarent Biopharma, Inc. | 240 | 2026-07-01 | 2026-07-16 |
| Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015) Tulisokibart, Placebo - Psoriatic Arthritis | Phase 2 | Active not recruiting | Merck Sharp & Dohme LLC | 140 | 2026-04-20 | 2026-10-20 |
| A Phase I/Ⅱ Clinical Trial for Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in the Treatment of Ankylosing Spondylitis HS_SW01 cells injection - Ankylosing Spondylitis | Phase 1 / Phase 2 | Not yet recruiting | Shenzhen Huishan Biotechnology Co., Ltd. | 18 | 2026-04-10 | 2026-04-20 |
| Efficacy and Safety of Xeligekimab in the Treatment of Non-Radiographic Axial Spondyloarthritis Xeligekimab injection - Nr-axial Spondyloarthritis, Non-Radiographical Axial Spondyloarthritis | Phase 2 / Phase 3 | Not yet recruiting | Lingli Dong | 40 | 2026-01-31 | 2026-01-14 |
| A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic Arthritis D-2570, Placebo - PsA (Psoriatic Arthritis) | Phase 2 | Recruiting | InventisBio Co., Ltd | 222 | 2026-01-16 | 2026-04-22 |
| A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis JNJ-88545223, Placebo - Arthritis, Psoriatic | Phase 2 | Active not recruiting | Janssen Research & Development, LLC | 157 | 2026-01-15 | 2026-11-03 |
| A Study of Picankibart in Patients With Active Psoriatic Arthritis Placebo, Picankibart - Psoriatic Arthritis | Phase 2 / Phase 3 | Recruiting | Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. | 222 | 2025-12-18 | 2026-03-20 |
| Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty Methotrexate, Sulfasalazine, Hydroxychloroquine - Rheumatic Disease | Phase 2 | Recruiting | NYU Langone Health | 80 | 2025-12-12 | 2026-07-09 |
| A Study of SPY072 in Rheumatic Disease SPY002-072, Placebo - Rheumatoid Arthritis, Psoriatic Arthritis | Phase 2 | Active not recruiting | Spyre Therapeutics, Inc. | 285 | 2025-08-21 | 2026-06-05 |
| EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1) Part A - Single Ascending Dose (SAD) in Healthy Human Volunteers, Part B - Multiple Ascending Dose (MAD) in participants with axSpA, Part C - Safety expansion cohort in participants with axSpA - Axial Spondyloarthritis (AxSpA) | Phase 1 / Phase 2 | Recruiting | Grey Wolf Therapeutics | 140 | 2025-07-28 | 2026-09-18 |
| Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis Lutikizumab, Risankizumab, ABBV-701 - Psoriatic Arthritis | Phase 2 | Recruiting | AbbVie | 300 | 2025-04-11 | 2026-11-09 |
| Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases Mesenchymal Stem Cells, Placebo - Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE) | Phase 1 / Phase 2 | Enrolling by invitation | National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | 200 | 2025-02-01 | 2025-03-21 |
| Efficacy and Safety of SCT650C in Participants With Axial Spondyloarthritis SCT650C - Axial Spondyloarthritis | Phase 2 | Unknown | Sinocelltech Ltd. | 168 | 2024-07-01 | 2024-01-09 |
| Fecal Microbiota Transplantation in Axial Spondyloarthritis FMT, Placebo - Axial Spondyloarthritis, Ankylosing Spondylitis | Phase 2 | Recruiting | University Hospital of North Norway | 99 | 2024-06-01 | 2026-08-14 |
| The Efficacy of Fecal Microbiota Transplatation on Axial Spondyloarthritis Patients Resistant to Conventional Treatment active FMT, Placebo - Axial Spondyloarthritis | Phase 2 / Phase 3 | Recruiting | Assistance Publique - Hôpitaux de Paris | 20 | 2024-03-28 | 2024-04-09 |
Showing 20 of 131. Sign in to see all of them.
Arthritis, Psoriatic (65) · Spondylitis, Ankylosing (57) · Arthritis, Rheumatoid (17) · Axial Spondyloarthritis (15) · Arthritis (14) · Psoriasis (13) · Spondylarthritis (9) · Non-Radiographic Axial Spondyloarthritis (6) · Spondylitis (6) · Joint Diseases (4) · Musculoskeletal Diseases (4) · Osteoarthritis (4) · Arthritis, Juvenile (3) · Crohn Disease (3)
Bone Diseases (129) · Spinal Diseases (128) · Joint Diseases (127) · Musculoskeletal Diseases (127) · Spondylitis (125) · Spondylarthritis (122) · Arthritis (117) · Ankylosis (70) · Skin and Connective Tissue Diseases (70) · Skin Diseases, Papulosquamous (67) · Skin Diseases (66) · Axial Spondyloarthritis (56) · Psoriasis (54) · Immune System Diseases (20)
tofacitinib (7) · Adalimumab (6) · Etanercept (6) · bimekizumab (6) · risankizumab (5) · secukinumab (5) · GLPG0634 (4) · Infliximab (4) · Sulfasalazine (4) · Ustekinumab (4) · Abatacept (3) · Meloxicam (3) · Methotrexate (3) · apremilast (3) · golimumab (3)
Charite University, Berlin, Germany (10) · AbbVie (7) · Novartis Pharmaceuticals (6) · Lakefront Biotherapeutics NV (4) · Amgen (3) · Janssen Research & Development, LLC (3) · Pfizer (3) · UCB Biopharma SRL (3) · ACELYRIN Inc. (2) · Advanced Accelerator Applications (2) · Assistance Publique - Hôpitaux de Paris (2) · Biocad (2) · Brigham and Women's Hospital (2) · Bristol-Myers Squibb (2) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (2)
United States (50) · Germany (38) · Poland (33) · Spain (27) · Czechia (25) · China (22) · Hungary (20) · Canada (19) · Russia (14) · Bulgaria (12) · Netherlands (12) · Belgium (10) · Ukraine (10) · United Kingdom (10) · Australia (8)
Joachim Sieper, MD (3) · Joachim Sieper, Prof. (3) · Pille Harrison, MD, DPhil, MRCP (UK) (2)
PMID 40194794, PMID 41807031, PMID 24476416, PMID 35789257, PMID 35833532, PMID 35931879, PMID 36178584, PMID 39890205, PMID 18576337, PMID 19217154, PMID 19587341, PMID 20231202, PMID 20461780, PMID 21128258, PMID 21425247, PMID 22265264, PMID 22751595, PMID 22867975, PMID 22984171, PMID 23588944, PMID 23625982, PMID 23686466, PMID 23786760, PMID 24035250, PMID 24389297, PMID 24550171, PMID 25028375, PMID 25140041, PMID 26248638, PMID 26773108, PMID 27059799, PMID 28130206, PMID 29100842, PMID 29615661, PMID 29855175, PMID 29893222, PMID 29945918, PMID 30032191, PMID 30053825, PMID 30360969, PMID 30360970, PMID 30376130, PMID 30472651, PMID 30480772, PMID 30739254, PMID 31025924, PMID 31349876, PMID 31421033, PMID 31624837, PMID 32035552
2017 (6), 2014 (4), 2009 (3), 2016 (3), 2025 (3), 2008 (2), 2015 (2), 2018 (2), 2019 (2), 2005 (1), 2023 (1), KL2TR003168 (1), P20GM130414 (1), P60AR047782 (1)